CASEBIA THERAPEUTICS Trademark

Trademark Overview


On Monday, July 17, 2017, a trademark application was filed for CASEBIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CASEBIA THERAPEUTICS trademark a serial number of 87531199. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 23, 2021. This trademark is owned by Casebia Therapeutics Limited Liability Partnership. The CASEBIA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders

Research and development of human therapeutics using gene editing; pharmaceutical research and development services

General Information


Serial Number87531199
Word MarkCASEBIA THERAPEUTICS
Filing DateMonday, July 17, 2017
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 23, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 23, 2021
Attorney NameSusan Neuberger Weller
Law Office Location CodeM60
Employee NameNASSERGHODSI, SAHAR
CorrespondentSusan Neuberger Weller
Mintz, Levin, Cohn, Ferris, Glovsky and
Suite 900
Washington, DC 20004

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of of the words "CASEBIA" above "THERAPEUTICS", to the left of which are the images of a circle, square and pentagon, presented in an overlapping vertical arrangement.
Goods and ServicesGene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Goods and ServicesResearch and development of human therapeutics using gene editing; pharmaceutical research and development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 24, 2017
Primary Code042
First Use Anywhere DateFriday, June 9, 2017
First Use In Commerce DateFriday, June 9, 2017

Trademark Owner History


Party NameCasebia Therapeutics Limited Liability Partnership
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB

Party NameCasebia Therapeutics Limited Liability Partnership
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB

Trademark Events


Event DateEvent Description
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 21, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, April 21, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 21, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 19, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 19, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 12, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 12, 2018LETTER OF SUSPENSION E-MAILED
Thursday, April 12, 2018SUSPENSION LETTER WRITTEN
Thursday, April 12, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, April 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, April 9, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 9, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2017NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2017NON-FINAL ACTION WRITTEN
Monday, October 16, 2017ASSIGNED TO EXAMINER
Tuesday, July 25, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 20, 2017NEW APPLICATION ENTERED IN TRAM